Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshio Ozaki is active.

Publication


Featured researches published by Toshio Ozaki.


Clinical & Experimental Allergy | 1983

Characteristics of the cellular composition, especially the lymphocyte sub‐populations of bronchoalveolar lavage fluid from patients with summer‐type hypersensitivity pneumonitis

Takuro Nakayama; Suzumu Yasuoka; M. Mitsui; Tomohiro Kawano; Toshio Ozaki; Eiro Tsubura

The pathogenesis of summer‐type hypersensitivity pneumonitis, which often occurs in Japan, was examined by analysing the cell profile, especially the lymphocyte sub‐populations, of bronchoalveolar lavage fluid from these patients: twenty‐two normal volunteers and fourteen patients with localized lung cancer as controls. Lymphocyte sub‐populations were determined by the micro‐testplate method. In the bronchial fluid of the summer hypersensitivity group, the total cell number was much higher (five to ten times) than in the control groups, and the percentage of lymphocytes reached 84‐2 + 5.1 (mean + s.e. mean); the percentage of T lymphocytes was significantly increased (95.6 + 1.0), but that of B lymphocytes (3.2 + 0.6) was similar to that of the control groups, though the absolute numbers of B and T lymphocytes were higher than in the control groups. In the peripheral blood of the summer hypersensitivity group, the percentage of B lymphocytes was significantly higher than that found in the normal volunteers, but that of T lymphocytes was not increased. Cellular changes in bronchial fluid were more evident than changes seen by X‐ray examination and are considered to be a good parameter of the severity of hypersensitivity pneumonitis. It is considered that cell‐mediated immunity as well as the Arthus reaction may be intimately related to the pathogenesis of summer‐type hypersensitivity pneumonitis.


Experimental Lung Research | 1990

Cytotoxic Factor for Fibroblasts in Bronchoalveolar Lavage Fluid of Bleomycin-Treated Rats

Kenji Tani; Susumu Yasuoka; Fumitaka Ogushi; Toshio Ozaki; Nobuya Sano; Takeshi Ogura

The mechanisms of lung injury and fibrosis in diffuse interstitial lung diseases were studied by tests on the in vitro effect of bronchoalveolar lavage fluid (BALF) from bleomycin-treated rats on quiescent fibroblasts in culture. The BALF was obtained on days 2, 3, 6, 15, and 29 after intratracheal administration of bleomycin. Cytotoxic activity was detected in the BALF only on day 2. The factor responsible for the cytotoxic activity was detected in 50-70% ammonium sulfate fraction, and lost 10% of its activity after 30 min at 56 degrees C, 75% after 10 min at 80 degrees C, and all activity after 10 min at 100 degrees C. The factor was completely precipitated by 60% acetone and was not extractable with ether. In ion exchange chromatography, the factor was eluted with the main fraction of protein, and gel filtration indicated that it had a molecular weight of 60-70 kDa. Histological examination showed disappearance of the normal alveolar architecture on day 2, and pulmonary fibrosis on day 15. Thus the cytotoxic factor may be one of factors responsible for lung injury and may act as trigger for subsequent fibrosis in bleomycin-induced lung damage.


American Journal of Respiratory Cell and Molecular Biology | 1991

Thrombin Enhances Lung Fibroblast Proliferation in Bleomycin-induced Pulmonary Fibrosis

Kenji Tani; Susumu Yasuoka; Fumitaka Ogushi; Kanji Asada; Kenji Fujisawa; Toshio Ozaki; Nobuya Sano; Takeshi Ogura


The American review of respiratory disease | 1992

Neutrophil Chemotactic Factors in the Respiratory Tract of Patients with Chronic Airway Diseases or Idiopathic Pulmonary Fibrosis

Toshio Ozaki; Hideki Hayashi; Kenji Tani; Fumitaka Ogushi; Susumu Yasuoka; Takeshi Ogura


Chest | 1992

Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis

Toshio Ozaki; Seiichiro Nakahira; Kenji Tani; Fumitaka Ogushi; Susumu Yasuoka; Takeshi Ogura


The American review of respiratory disease | 2015

Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor.

J. Lacronique; Stephen I. Rennard; Peter B. Bitterman; Toshio Ozaki; Ronald G. Crystal


American Journal of Respiratory Cell and Molecular Biology | 1993

Factors that Stimulate the Proliferation and Survival of Eosinophils in Eosinophilic Pleural Effusion: Relationship to Granulocyte/Macrophage Colony-stimulating Factor, Interleukin-5, and Interleukin-3

Yoichi Nakamura; Toshio Ozaki; Toshihiko Kamei; Koji Kawaji; Kayo Banno; Satoru Miki; Kenji Fujisawa; Susumu Yasuoka; Takeshi Ogura


The American review of respiratory disease | 1993

Increased Granulocyte/Macrophage Colony-stimulating Factor Production by Mononuclear Cells from Peripheral Blood of Patients with Bronchial Asthma

Youichi Nakamura; Toshio Ozaki; Toshihiko Kamei; Koji Kawaji; Kayo Banno; Satoru Miki; Kenji Fujisawa; Susumu Yasuoka; Takeshi Ogura


The American review of respiratory disease | 1982

Glucocorticoid receptors in bronchoalveolar cells from patients with idiopathic pulmonary fibrosis.

Toshio Ozaki; Tadashi Nakayama; Hisayasu Ishimi; Tomohiro Kawano; Susumu Yasuoka; Eiro Tsubura


The American review of respiratory disease | 1990

Regulatory Effect of Prostaglandin E2 on Fibronectin Release from Human Alveolar Macrophages

Toshio Ozaki; Hiroki Moriguchi; Youichi Nakamura; Toshihiko Kamei; Susumu Yasuoka; Takeshi Ogura

Collaboration


Dive into the Toshio Ozaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eiro Tsubura

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Tani

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge